Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (14) GO Terms (9) Nucleotides (80) Proteins (46) Interactants (34) Wiki
XB-GENEPAGE-1005778

Papers associated with drd2



???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

referenced by:


Dopamine-induced arrestin recruitment and desensitization of the dopamine D4 receptor is regulated by G protein-coupled receptor kinase-2., Burström V, Ågren R, Betari N, Valle-León M, Garro-Martínez E, Ciruela F, Sahlholm K., Front Pharmacol. January 1, 2023; 14 1087171.          


Dopamine D2 Receptor Agonist Binding Kinetics-Role of a Conserved Serine Residue., Ågren R, Stepniewski TM, Zeberg H, Selent J, Sahlholm K., Int J Mol Sci. April 15, 2021; 22 (8):                     


Ligand with Two Modes of Interaction with the Dopamine D2 Receptor-An Induced-Fit Mechanism of Insurmountable Antagonism., Ågren R, Zeberg H, Stępniewski TM, Free RB, Reilly SW, Luedtke RR, Århem P, Ciruela F, Sibley DR, Mach RH, Selent J, Nilsson J, Sahlholm K., ACS Chem Neurosci. October 7, 2020; 11 (19): 3130-3143.            


The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation., Ågren R, Århem P, Nilsson J, Sahlholm K., Int J Neuropsychopharmacol. December 1, 2018; 21 (12): 1102-1108.    


Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease., Stahl K, Rahmani S, Prydz A, Skauli N, MacAulay N, Mylonakou MN, Torp R, Skare Ø, Berg T, Leergaard TB, Paulsen RE, Ottersen OP, Amiry-Moghaddam M., PLoS One. January 1, 2018; 13 (3): e0194896.                


RGS4 regulates partial agonism of the M2 muscarinic receptor-activated K+ currents., Chen IS, Furutani K, Inanobe A, Kurachi Y., J Physiol. March 15, 2014; 592 (6): 1237-48.            


Typical and atypical antipsychotics do not differ markedly in their reversibility of antagonism of the dopamine D2 receptor., Sahlholm K, Marcellino D, Nilsson J, Ögren SO, Fuxe K, Århem P., Int J Neuropsychopharmacol. January 1, 2014; 17 (1): 149-55.


Arrestin-dependent but G-protein coupled receptor kinase-independent uncoupling of D2-dopamine receptors., Celver J, Sharma M, Thanawala V, Christopher Octeau J, Kovoor A., J Neurochem. October 1, 2013; 127 (1): 57-65.


RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors., Celver J, Sharma M, Kovoor A., J Neurochem. August 1, 2010; 114 (3): 739-49.


Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent., Mayfield RD, Zahniser NR., Mol Pharmacol. January 1, 2001; 59 (1): 113-21.


Genomic analysis and functional expression of canine dopamine D2 receptor., Myeong H, Jeoung D, Kim H, Ha JH, Lee Y, Kim KH, Park C, Kaang BK., Gene. October 17, 2000; 257 (1): 99-107.


The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors. Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors., Verrall S, Ishii M, Chen M, Wang L, Tram T, Coughlin SR., J Biol Chem. March 14, 1997; 272 (11): 6898-902.


Functional expression and characterization of human D2 and D3 dopamine receptors., Potenza MN, Graminski GF, Schmauss C, Lerner MR., J Neurosci. March 1, 1994; 14 (3 Pt 2): 1463-76.

???pagination.result.page??? 1